8-K
Current Report
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-019198
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading sabs20230629c_8k.htm…